Authors argue that a substantial subgroup of people with ADHD exhibits a circadian rhythm disorder phenotype that meaningfully interacts with core symptoms. Convergent evidence shows very high rates of insomnia and sleep disturbance (up to ~80% of adults and ~82% of children), prevalent evening chronotype and delayed sleep-wake timing (around 73-78%), and objective phase delays in biological markers: dim‑light melatonin onset delayed by roughly 45 minutes in children and 90 minutes in adults. Circadian dysregulation extends to blunted and delayed cortisol rhythms, reduced pineal gland volume, attenuated peripheral clock‑gene rhythms (BMAL1/PER2), and altered melatonin secretion patterns (including elevated daytime melatonin in some children that normalizes with stimulant treatment). These findings persist after accounting for common comorbidities and are corroborated by actigraphy and hormonal measures.
Clinical implications are practical and testable: melatonin and morning bright light reliably advance circadian phase in ADHD and phase shifts correlate with symptom improvement, while structured sleep programs improve sleep quality and functioning in children. Authors recommend a behavioral‑first clinical pathway including routine screening for sleep/circadian disturbance, chronotype assessment and sleep tracking (with DLMO testing when feasible), fixed wake times, morning bright light exposure, evening light restriction and screen hygiene, regularized zeitgebers, and selective low‑dose melatonin for confirmed DLMO delays. They call for rigorously stratified trials to define responder phenotypes and optimize chronotherapy protocols.
Summary generated by AI from the linked article. hn.today is not affiliated with Hacker News or Y Combinator.